Michael D. Amatangelo,Chad Bjorklund,Anjan Thakurta,Xiankang Hong,Mariana Cota
申请号：
US16588318
公开号：
US20200101058A1
申请日:
2019.09.30
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Provided herein are methods of treating and/or managing cancers, which comprise administering to a patient Compound A, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof in combination with daratumumab. Additionally, provided herein are methods of treating and/or managing cancers, which comprise administering to a patient Compound A, or an enantiomer or a mixture of enantiomers thereof, or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof in combination with daratumumab and dexamethasone.
